Tissue Banking Market Analysis of Key Players and Forecasts to 2032

 The latest report by IMARC Group, titled “Tissue Banking Market Report by Product (Equipment, Media and Consumables), Application (Therapeutics, Medical Research, and Others), Tissue Type (Cardiovascular Tissue, Lung Tissue, Kidney Tissue, Pancreas Tissue, Liver Tissue, Eye Tissue, and Others), and Region 2024-2032“, offers a comprehensive analysis of the industry, which comprises insights on the global tissue banking market forecast. The global market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 10% during 2024-2032.

Factors Affecting the Growth of the Global Tissue Banking Industry:

• Increasing Prevalence of Chronic Diseases:

The Tissue Banking Market is expanding due to the global rise in chronic diseases like diabetes, cardiovascular disorders, and cancer. This increase leads to a greater need for complex medical interventions, such as organ transplants and reconstructive surgeries, which depend on the availability of healthy tissues and organs. Tissue banks play a vital role in providing these essential materials. Furthermore, the demand for tissue banking is driven by the aging global population, which is more prone to chronic diseases and degenerative conditions. Consequently, as the prevalence of these diseases continues to increase, the need for tissue banks to supply viable tissues for treatments and research purposes also rises, thereby propelling market growth in this sector.

• Government Initiatives:

Government initiatives and funding have significantly driven the market forward by recognizing and supporting the crucial role of tissue banking in healthcare. This global acknowledgment has led to the implementation of supportive policies and funding programs, particularly in areas such as research in tissue engineering and regenerative medicine, alongside the establishment of stringent regulations and standards governing tissue donation, procurement, and storage. These initiatives offer not only financial backing but also ensure adherence to quality norms, guaranteeing the safe and ethical sourcing of tissues. Moreover, public awareness efforts promoting tissue donation have spurred a rise in donor numbers, further amplifying the expansion of the tissue banking market. This governmental backing serves as a testament to the sector's importance in advancing medical science and enhancing patient outcomes.

• Technological Advancements:

Advancements in bio preservation technologies drive the market significantly through the development and enhancement of methods for storing biological materials like tissues and organs at low temperatures to maintain their viability for medical purposes. These technological improvements have increased the efficacy and longevity of preserved tissues, making them more suitable for transplants and medical research. Consequently, there is a rising demand for tissue banking services across diverse medical fields, including organ transplantation, regenerative medicine, and therapeutic applications. The integration of cutting-edge technologies like cryopreservation and vitrification has further elevated the market, as these methods enable long-term storage without compromising tissue integrity, thereby unlocking new possibilities in biomedical research and treatment.

Competitive Landscape with Key Player:

• AMS Biotechnology
• Beckman Coulter Inc. (Danaher Corporation)
• Bio-Rad Laboratories Inc.
• Brooks Life Sciences Inc. (Brooks Automation Inc.)
• Eppendorf AG
• Merck KGaA
• PHC Corporation
• QIAGEN N.V.
• Sartorius AG
• Taylor-Wharton
• Thermo Fisher Scientific Inc.
• VWR International LLC (Avantor Inc).

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/tissue-banking-market/requestsample

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

• Equipment
  • Cryopreservation Equipment
  • Thawing Equipment
  • Quality Control Equipment
  • Others
• Media and Consumables 

Equipment accounts for the largest market share as the tissue banking industry requires a range of specialized equipment for the collection, processing, storage, and preservation of biological tissues.

Breakup by Application:

• Therapeutics
• Medical Research
• Others 

Therapeutics holds the largest market share due to the advancements in regenerative medicine, tissue transplantation, and cell-based therapies.

Breakup by Tissue Type:

• Cardiovascular Tissue
• Lung Tissue
• Kidney Tissue
• Pancreas Tissue
• Liver Tissue
• Eye Tissue
• Others

Cardiovascular tissue represents the leading segment due to the growing prevalence of cardiovascular diseases and escalating need for transplant surgeries to address these conditions.

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America leads the market as it boasts a well-developed healthcare infrastructure with state-of-the-art facilities and a robust network of hospitals and research institutions.

Tissue Banking Market Trends:

The growing need for stem cell banking is fueled by the potential of stem cells in treating a wide range of diseases and injuries. Tissue banks are progressively storing and offering access to stem cell samples for therapeutic use. Additionally, tissue banks are embracing advanced cryopreservation methods to improve the durable storage of tissues and cells, ensuring the maintenance of tissue integrity and viability over prolonged periods. Furthermore, tissue banking is aligning with the personalized medicine trend, banking tissues and cells to correspond to individual patient profiles, enabling customized treatments and therapies.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163